Toll Free: 1-888-928-9744
Published: May, 2014 | Pages:
56 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Sarepta Therapeutics, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Sarepta Therapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the Sarepta Therapeutics, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Sarepta Therapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Sarepta Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Sarepta Therapeutics, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Sarepta Therapeutics, Inc.'s pipeline products Reasons to buy - Evaluate Sarepta Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Sarepta Therapeutics, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Sarepta Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Sarepta Therapeutics, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Sarepta Therapeutics, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Sarepta Therapeutics, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 5 Sarepta Therapeutics, Inc. Snapshot 6 Sarepta Therapeutics, Inc. Overview 6 Key Information 6 Key Facts 6 Sarepta Therapeutics, Inc. - Research and Development Overview 7 Key Therapeutic Areas 7 Sarepta Therapeutics, Inc. - Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products - Monotherapy 11 Sarepta Therapeutics, Inc. - Pipeline Products Glance 12 Sarepta Therapeutics, Inc. - Clinical Stage Pipeline Products 12 Phase II Products/Combination Treatment Modalities 12 Phase I Products/Combination Treatment Modalities 13 Sarepta Therapeutics, Inc. - Early Stage Pipeline Products 14 Preclinical Products/Combination Treatment Modalities 14 Discovery Products/Combination Treatment Modalities 15 Sarepta Therapeutics, Inc. - Drug Profiles 16 eteplirsen 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 AVI-7288 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 radavirsen 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 AVI-6006 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 AVI-7012 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Bacterial PPMO 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 SRP-4044 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 SRP-4045 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 SRP-4050 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 SRP-4053 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 Antisense Oligonucleotide for Infectious Diseases 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 Antisense Oligonucleotide for Rare Diseases 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 SRP-4008 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 SRP-4052 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 SRP-4055 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 Viral PMO-X 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 Sarepta Therapeutics, Inc. - Pipeline Analysis 34 Sarepta Therapeutics, Inc. - Pipeline Products by Target 34 Sarepta Therapeutics, Inc. - Pipeline Products by Route of Administration 35 Sarepta Therapeutics, Inc. - Pipeline Products by Molecule Type 36 Sarepta Therapeutics, Inc. - Pipeline Products by Mechanism of Action 37 Sarepta Therapeutics, Inc. - Recent Pipeline Updates 38 Sarepta Therapeutics, Inc. - Dormant Projects 49 Sarepta Therapeutics, Inc. - Discontinued Pipeline Products 50 Discontinued Pipeline Product Profiles 50 AVI-4065 50 AVI-5126 50 AVI-6002 50 AVI-7537 51 Sarepta Therapeutics, Inc. - Company Statement 52 Sarepta Therapeutics, Inc. - Locations And Subsidiaries 54 Head Office 54 Other Locations & Subsidiaries 54 Appendix 55 Methodology 55 Coverage 55 Secondary Research 55 Primary Research 55 Expert Panel Validation 55 Contact Us 56 Disclaimer 56
List of Tables Sarepta Therapeutics, Inc., Key Information 6 Sarepta Therapeutics, Inc., Key Facts 6 Sarepta Therapeutics, Inc. - Pipeline by Indication, 2014 9 Sarepta Therapeutics, Inc. - Pipeline by Stage of Development, 2014 10 Sarepta Therapeutics, Inc. - Monotherapy Products in Pipeline, 2014 11 Sarepta Therapeutics, Inc. - Phase II, 2014 12 Sarepta Therapeutics, Inc. - Phase I, 2014 13 Sarepta Therapeutics, Inc. - Preclinical, 2014 14 Sarepta Therapeutics, Inc. - Discovery, 2014 15 Sarepta Therapeutics, Inc. - Pipeline by Target, 2014 34 Sarepta Therapeutics, Inc. - Pipeline by Route of Administration, 2014 35 Sarepta Therapeutics, Inc. - Pipeline by Molecule Type, 2014 36 Sarepta Therapeutics, Inc. - Pipeline Products by Mechanism of Action, 2014 37 Sarepta Therapeutics, Inc. - Recent Pipeline Updates, 2014 38 Sarepta Therapeutics, Inc. - Dormant Developmental Projects,2014 49 Sarepta Therapeutics, Inc. - Discontinued Pipeline Products, 2014 50 Sarepta Therapeutics, Inc., Other Locations 54
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.